The healthcare and pharmaceutical industries are challenged by diseases that don’t respond well to current drugs. By developing new chemical tools and technologies, MIT researchers are working to identify new approaches to target previously complex disease mechanisms in order to bring more effective therapeutics to patients. In addition, MIT-connected startup companies are working to commercialize new methods of delivery, manufacturing, and better use of data to further improve and expedite medical treatment.